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The screening of natural sources such as plant extracts and fermentation products in search of new pharmacologically active principles led to the discovery of many clinically useful drugs that play a key role in the treatment of human diseases. A recent review pointed out that approximately 60% of the anti-tumour and anti-infective agents that are commercially available or in late stages of clinical trials today are of natural product origin. Historically, majority of the drugs originated from natural products like cyclosporine, paclipaxel and camptothecins saw the light by traditional in vitro cell based assays like antibacterial, antifungal or cytotoxic before their real molecular biological targets were identified. Bioactive principles were sought in earnest in the very early part of the nineteenth century, during which investigation of well known medicinal plants lead to the discovery of a number of biologically active alkaloids. Some of them like morphine, atropine, papavarine and codeine became cornerstones of many aspects of drug discovery. Today, with the advent of genomic research, high-throughput screening, combinatorial chemistry and newer molecular biology tools for developing bioassays, more sophisticated biological assays in addition to cell-based assays are being employed routinely in the drug discovery paradigm. As a result, a large number of natural products especially plant derived drugs continue to be discovered on the basis of traditional knowledge like ayurveda and siddha etc. 

It is increasingly being realized that many age related human diseases such as heart disease, cancer, diabetic complications, inflammation, arthritis, immune system impairment and brain dysfunction are the result of bimolecular and cellular damages by free radicals and free radical scavengers could play an important role in preventing such diseases. Several cancer chemo preventive, antiatherolcerotic and antistrike exhibit antioxidant activity through their ability to scavenge variety of free radicals, these developments have accelerated the global efforts to identify the natural resources bearing richer contents of antioxidant principles, particularly from the medicinal plants used in traditional therapeutic practices.

Natural products are of wide usage in the traditional systems of medicine like Ayurveda, Siddha and Chinese etc., in their crude form. Among the natural products, plants possess great chemical versatility. Because of ecological necessity, the variety of secondary metabolites produced by plants is broader than those of other organisms. Plant derived pharmaceuticals and phytochemicals retain their historic significance in the drug industry. Medicinal plants have medicinal properties, but in few plants or their phytochemical constituents have been proven by rigorous science or approved by regulatory agencies such as the United States Food and Drug Administration or European Food Safety Authority to have medicinal effects. These can be about traditional healing uses of plants, allopathic medicines derived from the traditional medicinal plants, and pharmacological research results about a plant.  
Chapter I:  Isolation of new icetexanes from the hexane extract of stem of Premna tomentosa and their cytotoxicity studies 
Premna tomentosa L. (Verbanaceae) commonly called as ‘Pudangainari’ and ‘Krishnapalai’ is a medicinal plant used extensively for the treatment of various disorders. The genus Premna (Verbanaceae) consists of about 35 species distributed throughout the tropical and subtropical regions of the world. All Premna species are well known medicinal plants and are used for stomach disorders and diarrhoea in Indian traditional system of medicine and other regions of Asia. Premna tomentosa is a large, spinous and evergreen shrub, found throughout India in dry regions especially in Punjab, Kashmir and Northwestern frontier province. It is a moderate sized deciduous tree with shoots, leaves and inflorescence densely clothed with a tawny yellow stellate tomentum. Bark is light grayish-brown, like that of teak and flowers are greenish yellow. Indian medicine claims a lasting cure for hepatic disorders through oral administration of an extract of Premna tomentosa. In traditional medicine, Premna tomentosa has also been used to treat stomach disorders and diarrhoea. The leaves are said to possess diuretic properties. Earlier studies have shown that the methanolic extract of Premna tomentosa leaves afforded significant protection against acetaminophen-induced hepatotoxicity in rats by its antioxidant property.

The Premna tomentosa plant material was collected from Tirumala forest, Tirupati, Andhra Pradesh. The whole stem was shade dried, powdered and sequentially extracted with hexane, chloroform and acetone in a soxhlet apparatus. The resulting extract was then concentrated under vaccum to obtain a residue. The residue was chromatographed over column of silica gel (60-120 mesh) and eluted with n-hexane/ethyl acetate combinations of increasing polarity. From the hexane extract three new compounds F, G, and H were isolated for the first time from nature. The new compounds are icetexane type diterpenoids. The structures of the new compounds were elucidated from analyses of 1D and 2D NMR spectroscopic data like 1H NMR, 13C NMR, 1H-1H COSY, NOESY, HSQC and HMBC. Anti-cancer activity of all the isolated compounds along the new compounds was investigated.
The known compounds are identified as Lupeol, Betulin, 2(4-methoxyphenyl)-2-butanone, β-Sitosterol, β-Sitosterol-3-O-glycoside. Their structures were established by comparing their spectral data with the values reported in literature.

Compound F is a new icetexane diterpenoid with the molecular formula C20H30O4, determined from the HRESIMS that revealed a molecular ion peak at m/z 333.2054 implying six degrees of unsaturation. The IR spectrum of compound F indicated the presence of hydroxyl groups at 3442cm-1 and aromatic moiety 1634, 1452cm-1. The UV spectrum displayed absorption maxima at 280nm indicative of simple phenyl ring. Initial interpretation of DEPT and 13C NMR spectral data showed that majority of the proton signals were from methylene protons. The 1H NMR spectrum of compound F, measured in CDCl3 contained two methyl singlets at  0.95 (H3-18) and 0.98 (H3-19) and one methyl doublet at  1.76 (d, J = 7.2 Hz, H3-17). It also displayed signals attributable to one oxygen-bearing methylene at  3.79-3.84 (m, H-16) and a multiplet at  3.41-3.46 from a deshielded methine (H-15). Furthermore, two proton resonances at  6.08 and 8.12 each (1H, s), which did not show any correlation with all the carbons in the HSQC spectrum, were assigned to hydroxyl groups. The 1H NMR also showed characteristic AB system of C-20 methylene protons at  2.47 (d, J = 14.1 Hz, H-20a),  3.17 (d, J = 14.1 Hz, H-20b), together with overlapped multiplets due to five methylenes between  1.28 and 2.60 were suggested that compound F is an icetexane type diterpene, with the structure similar to that of demethylsalvicanol. The major portion of the icetexane skeleton frame work, which is composed of mostly methylene carbons, assembled through the interpretation of 2D NMR (COSY, HMBC, and HSQC) correlations. Interpretation of 1H-1H COSY spectra revealed the connectivities between H-1/H-2/H-3, H-5/H-6, and H-6/H-7 protons. The low field quaternary carbon at  70.24 (C-10) was attributed to a hydroxyl group bearing carbon due to its HMBC correlations from H-1, H-20 and H-5. In the HMBC spectrum  two hydroxyls resonating at  6.08 and 8.12 were assigned to C-11 and C-12 by the HMBC correlations from 11-OH to C-9 ( 118.67), C-12 ( 139.03), C-20 ( 41.21) and from 12-OH to C-11 ( 143.32), C-13 ( 135.33), respectively.

Moreover, aromatic proton at  6.34 (s, 1H) could be assigned to H-14 by its HMBC correlations with C-13 ( 135.33), C-8 ( 127.21) and C-9 ( 118.67). The 1H-1H COSY correlations from H3-17 through H-15 to H-16, in combination with HMBC correlations from H-15 to C-12, C-13 and C-14 were suggestive of isopropanol moiety in compound F. Finally, methine proton at  1.54-1.61 (1H, m) was assigned to H-5 as a result of its HMBC correlations with C-10 ( 70.24), C-6 ( 28.37) and correlation of CH3-19, CH3-18 to C-5. In addition, relative configuration of compound F was determined from biogenetic basis and by analysis of the 2D NOESY data. The configuration of the basic icetexane portion of compound F was assumed to be the same as that of known diterpenes bearing the same skeleton such as demethylsalvicanol. Its NOESY spectrum showed the correlations between H3-18/H-5; H-10/H-19. These data were in accordance with the -orientation of H3-19, OH-10 and -orientation of H-5 and H-18. Based on these data, the structure of compound F was identified as 8,11,13,icetexatriene-10,11,12,16-tetrol, a new diterpene and trivially named as icetexane-1.

Compound G is also a new icetexane diterpenoid with molecular formula defined as C20H30O3 that revealed a molecular ion peak at m/z 317.2084 [M+-H] in the HRESIMS indicating one oxygen atom less than in the case of compound F. The IR spectrum proved the existence of hydroxyl 3442 cm-1 and aromatic functionalities 1634, 1560cm-1. Both 1H and 13C NMR spectral data disclosed the same key structural features of compound F, including the same icetexane diterpene skeleton with isopropanol moiety. The difference in the 1H NMR spectrum of compound G with that of compound F was the substitution pattern of phenyl ring in which two aromatic methines at  6.89 (1H,s) and at  6.42 (1H,s) were shown. The DEPT experiment also proved the presence of two aromatic methine signals instead of one in case of compound F, which was associated with the absence of 1H NMR signal of 12-OH group. This finding was further confirmed by its HMBC correlations from H-12 ( 6.42, s) to C-13 ( 135.26) and C-11 ( 143.33). Isopropanol group was found to be attached at C-13 as evidenced by the HMBC correlations from H-15 (1H, m, 3.40-3.46) to C-12 (112.23) and C-14 ( 116.46). The proposed structure was further confirmed by the key HMBC correlations between H-2/C-1; H-2/-3; H-20/C-10; H3-18/C-5; H3-19/C-3; H3-18/C-4; H-5/C-6; H-5/C-10; H-14/C-9, C-12; OH-11/C-11, C-12, C-9; H3-17/C-15, C-16, C-13 and H-15/C-13, C-12, C-14. The relative stereochemistry at chiral centers was consistent with that of icetexane-1 (compound F) based on the analysis of NOESY spectrum as well as biogenetic considerations. NOE effects between H-5 with H3-18 and absence of the correlations between H-19 and H-5 indicated that -orientation of H3-19 and -orientation of H3-18 and H-5. Based on these discussions, compound G was identified as 8, 11,13 icetexatriene-10,11,16-triol, which is a new icetexane diterpene and trivially named as icetexane-2.

           The third new compound isolated was Compound H which was isolated as a colourless gum with the molecular formula C20H30O4 determined by HRESIMS (m/z 333.2077) [M+ - H], implying six degrees of unsaturation. IR absorption bands at 3442, 1632, and 1542 cm-1 suggested the presence of hydroxyl group and aromatic moiety. The IR, 1H NMR and 13C NMR spectra of compound H was almost identical to those of compound G except the difference due to hydroxyl group at C-7. This was indicated by the presence of an additional hydroxymethine group ( 4.8 dd;  72.64, CH-OH), which was confirmed by its HMBC correlations to C-6 ( 32.01), and in turn the correlations of H-6 ( 1.84-19.1, m) to C-5 ( 51.33) and C-7 ( 72.64) (fig. 3). Further, a set of oxymethylene protons resonated at  3.77-3.84 (H-16, m) and exhibited HMBC correlations of H-15 (1H, m, 3.42-3.48) to C-12 ( 112.12) and C-14 ( 118.01) indicating presence of isopropanol group. Relative stereochemistry of compound H was determnined from the NOESY correlations between H-5/H3-18, H-7/H-5 which were in agreement with the -orientation of H3-19 and -orientation of H3-18, H-7a and H-5. Thus, structure of compound H was confirmed as 8,11,13 icetexatriene-7,10,11,16-tetrol, which is a new icetexane diterpene and trivially named as icetexane-3.
                                         

Chapter II: Isolation of icetexane-4 & a novel isoxazole from the Chloroform extract of stem of Premna tomentosa and their cytotoxicity studies  
The second chapter describes the isolation and characterization of 6 compounds designated as A, B, C, D, E and F besides 3,4 dimethoxy benzaldehyde from the chloroform extract of the stem of Premna tomentosa. Compounds A, B, C and D, were identified as coniferaldehyde, acetoxy syringaldehyde, vanillin, vanillic acid.  Compounds E and F were identified as new icetexane-4 and 5-[2-methyl-6-(3-methylbut-2-enyloxy)phenyl]isoxazole  respectively.
            
Compound E is a new icetexane diterpenoid which was isolated as a gum. The molecular formula of compound E was determined as C20H28O4 from HRESIMS which revealed a molecular ion preak at m/z 331.2077 [M+-H] corresponding to seven degrees of unsaturation. The IR absorptions indicated the presence of hydroxyl 3442cm-1, ether 1230cm-1, and aromatic 1615 and 1510 cm-1 moieties. Extensive analysis of the NMR spectroscopic data revealed that the structure of compound E was closely related to compound F (from chapter I), possessing isopropanol group and aromatic ring. The presence of the aromatic ring was concluded from its 13C NMR spectrum  128.32, 134.80, 142.81, 144.19, 141.52 and 116.02 and isopropanol group located on the aromatic ring confirmed on basis of the HMBC correlations. On the basis of the molecular formula C20H28O4 revealed by HRESIMS, there were three remaining oxygen atoms in the molecule other than those associated with isopropanol. Two of these were due to hydroxyl groups resonationg at  6.08 and  8.12 attributed to C-11 and C-12 by the HMBC correlations 11-OH to C-11 ( 142.81), C-13 ( 141.52), respectively. From the 13C NMR spectrum, the carbon at  80.72 (C-7) should be attached to the oxygen atom as in the case of compound H (chapter I) and the carbon at  76.26 located at C-10 was also attached to an oxygen atom on the basis of the HMBC spectrum. Since there was only oxygen left, these two carbons were concluded to be attached to the same oxygen atom to form the cyclic ether functionality, which is commonly found in taxane diterpenes. The HMBC spectrum demonstrated the correlations between H-5/C-10, H-7/C-8 and H-7/C-10 verifying the presence of cyclic ether ring. Other key HMBC correlations were observed between H-2/C-1; H-2/c-3; H-20/C-10; H3-18/C-5; H3-19/C-3; H3-18/C-4; H-5/C-6; H-5/C-10; H-14/C-9, C-12; OH-11/C-11, C-12, C-9 and H3-17/C-15, C-167, C-13.

Investigation of 2D NMR data including HMBC and NOESY spectra enabled the assignment of all substituent groups and the relative configuration of compound E, which was comparable to compounds F, G and H (chapter I) as observed previously for all the above compounds, NOESY spectra revealed the interactions between H-5/H3-18, and H-5/H-7, which were in agreement with the -orientation of H3-19 and -orientation of H3-18, H-7 and H-5 based on the data, structure of compound E was identified as a 7,10-epoxy-8,11,13 icetexatriene-11,12,16-triol, which is new icetexane diterpene and trivially named as icetexane-4.





Compound F is a new isoxazole compound which was isolated as semi-solid. Its elemental composition was C15H17O2N with eight degrees of unsaturation was deduced from HREISMS which revealed a molecular ion peak at m/z: 244.1331 [M++H]. The odd mass indicated the presence of Nitrogen atom in this compound. The broad band decoupled 13C NMR spectrum of compound F showed 15 carbon signals that were sorted by DEPT and HSQC techniques as three methyls, one methylene, six methines and five quaternary carbons. The IR spectrum of compound F showed strong stretching for C=N at 2922cm-1, C-O-C stretching at 1505 cm-1. The 1H NMR spectrum of compound F displayed signals for three methyl groups at δ 1.70 (s, H-511), 1.822 (s, H-611), 2.326 (s, Ar-CH3), a doublet at δ 4.5 (d, H-211), a  triplet at δ 5.5 (t, H-311) characteristic of prenyl group. It also showed two doublets characteristic of isoxazole skeleton at δ 8.24 (d, H-3 J=1.8Hz) and 6.7 (d, H-4, J=1.8Hz). Two more doublets and one triplet was observed at δ 7.7 (d, H-31 J=1.8 Hz), 6.8 (d, H-51, J=8.4Hz), 7.1 (t, H-41, J=2.1Hz) were observed. Using the 1H NMR and 1H-1H COSY Correlations it was found that H-31, H-41, H-51 are adjacent to each other. The connectivity’s of the isoxazole unit and the other functional groups were established from its 1H-1H COSY, HSQC, and HMBC spectra. Thus based on the data, structure of compound F was identified as 5-[2-methyl-6-(3-methylbut-2-enyloxy)phenyl]isoxazole which is new isoxazole isolated for the first time from Premna tomentosa.                                                


 First Total Synthesis of 5-(2-methyl-6-(3-methylbut-2-enyloxy)phenyl)isoxazole:
The second half of chapter 2 deals with the synthetic approach towards first total synthesis of 5-(2-methyl-6-(3-methylbut-2-enyloxy)phenyl)isoxazole.The Isoxazole structure of exhibits an impressive array of functionality that includes two oxygenated carbons, one nitrogenated carbon. Our retrosynthetic analysis of Isoxazole is outlined in Scheme 1. Initial retrosynthetic disconnection of the C-3 and C-1 of A ring, the retrosynthetic disconnection of Prenyl group (Scheme 1), disconnection of carbonyl group which leads to the simple starting material ie., m-cresol.

We initiated our study of the synthesis of a Isoxazole namely 5-[2-methyl-6-(3-methylbut-2-enyloxy)phenyl]isoxazole by preparing variants of 2-ethynyl-1-methyl-3-(3-methylbut-2-enyloxy)benzene 6 and formaldehyde oxime which is formed insitu with the hope that we would unite the two compounds to give the final molecule. The m-cresol is treated with Tin(IV) chloride, tributyl amine, paraformaldehyde to give 2-hydroxy-6-methyl benzaldehyde. This 2-hydroxy-6-methylbenzaldehyde was treated with prenyl bromide in presence of potassium carbonate were the hydroxy group was prenylated to give 2-methyl-6-(3-methylbut-2-enyloxy)benzaldehyde . The carbonyl group of 2-methyl-6-(3-methylbut-2-enyloxy)benzaldehyde was treated with Triphenyl phosphine and Carbon tetrabromide at –17C in dry DCM to yield 2-(2,2-dibromovinyl)-1-methyl-3-(3-methylbut-2-enyloxy)benzene, which on Grignard reaction yielded 2-ethynyl-1-methyl-3-(3-methylbut-2-enyloxy)benzene. 
The 2-ethynyl-1-methyl-3-(3-methylbut-2-enyloxy)benzene was treated with the formaldehyde oxime with is formed insitu using formaldehyde and hydroxylamine hydrochloride to yield the final product ie., 5-[2-methyl-6-(3-methylbut-2-enyloxy) phenyl]isoxazole .



 Chapter III: Phytochemical investigation of stem of Alhagi pseudalhagi : Synthesis and cytotoxicity studies of Tetrahydroisoquinoline & its analogues 
The third chapter describes the isolation and characterization of 5 compounds designated as A, B, C, D and E besides stigmasterol from the ethanol/water extract of the stem of Alhagi pseudalhagi. Compounds A, B, C, D and E were identified as 2 (4-methoxy phenyl)-2-butanone, -Sitosterol, -Sitosterol –3-O-glucoside, Phenyl ethylamine and Tetrahydroisoquinoline respectively. Out of which the compound E was obtained in major amount and is a good cytotoxic compound itself, to enhance its activity different analogues were prepared using Boc-Protected Amino Acids.
For designing the analogs of Tetrahydroisoquinoline, the Nitrogen of Tetrahydroisoquinoline was linked to carboxylic group of different amino acids. This was achieved using HOBT and ethanolamine and a series of Boc Protected amino acids. Later Boc deprotection was done, using column chromatography the pure analogues were obtained in good yields. All these derivatives along with Tetrahydroisoquinoline have been evaluated for their cytotoxicity.


Scheme -1: Synthesis of Tetrahydroisoquinoline analogues




 





